Skip to main content
. 2023 Apr 8;43(6):1033–1039. doi: 10.1007/s00296-023-05314-5

Fig. 2.

Fig. 2

Survival analysis across subgroups of hybrid immunity with confirmed COVID-19 as an event assessed from 1st January 2022 till 15th March 2022. (V- Vaccine, I- Infection)